Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma.
Saved in:
| Title: | Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma. |
|---|---|
| Authors: | Ng LCK; Department of Haematology, Singapore General Hospital, Singapore, Singapore. lawrence.ng.c.k@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Singapore. lawrence.ng.c.k@singhealth.com.sg., Lee XH; Department of Haematology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Tan YC; Department of Haematology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Wong KL; Department of Haematology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore., Chow JCY; Department of Haematology, Singapore General Hospital, Singapore, Singapore., Ling VWT; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore., Thong EWS; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore., Chan EHL; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore., Chan WL; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore., Samuel M; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore., Poon MLM; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore. |
| Source: | Blood cancer journal [Blood Cancer J] 2025 Dec 29; Vol. 16 (1), pp. 17. Date of Electronic Publication: 2025 Dec 29. |
| Publication Type: | Journal Article; Systematic Review; Meta-Analysis |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41461632 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ng+LCK%22">Ng LCK</searchLink>; Department of Haematology, Singapore General Hospital, Singapore, Singapore. lawrence.ng.c.k@singhealth.com.sg.; Duke-NUS Medical School, Singapore, Singapore. lawrence.ng.c.k@singhealth.com.sg.<br /><searchLink fieldCode="AU" term="%22Lee+XH%22">Lee XH</searchLink>; Department of Haematology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tan+YC%22">Tan YC</searchLink>; Department of Haematology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wong+KL%22">Wong KL</searchLink>; Department of Haematology, Singapore General Hospital, Singapore, Singapore.; Duke-NUS Medical School, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chow+JCY%22">Chow JCY</searchLink>; Department of Haematology, Singapore General Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ling+VWT%22">Ling VWT</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Thong+EWS%22">Thong EWS</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chan+EHL%22">Chan EHL</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chan+WL%22">Chan WL</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Samuel+M%22">Samuel M</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Poon+MLM%22">Poon MLM</searchLink>; Department of Haematology-Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Yong Loo Lin School of Medicine, Singapore, Singapore. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Dec 29; Vol. 16 (1), pp. 17. <i>Date of Electronic Publication: </i>2025 Dec 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Systematic Review; Meta-Analysis – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41461632 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41408-025-01439-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 17 Titles: – TitleFull: Systematic review and meta-analysis: CAR-T vs bispecific antibody as third or later-line therapy for follicular lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ng LCK – PersonEntity: Name: NameFull: Lee XH – PersonEntity: Name: NameFull: Tan YC – PersonEntity: Name: NameFull: Wong KL – PersonEntity: Name: NameFull: Chow JCY – PersonEntity: Name: NameFull: Ling VWT – PersonEntity: Name: NameFull: Thong EWS – PersonEntity: Name: NameFull: Chan EHL – PersonEntity: Name: NameFull: Chan WL – PersonEntity: Name: NameFull: Samuel M – PersonEntity: Name: NameFull: Poon MLM IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 12 Text: 2025 Dec 29 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2044-5385 Numbering: – Type: volume Value: 16 – Type: issue Value: 1 Titles: – TitleFull: Blood cancer journal Type: main |
| ResultId | 1 |